Literature DB >> 22738800

Biomarkers for early diagnosis of hepatocellular carcinoma.

Alejandro Forner, Jordi Bruix.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22738800     DOI: 10.1016/S1470-2045(12)70271-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  46 in total

Review 1.  Associations between Cox-2 rs20417 and rs5275 polymorphisms and the risk of hepatocellular carcinoma: a meta analysis.

Authors:  Hexing Wu; Xiangwei Wu; Guoxing Wan; Shijie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  A single nucleotide polymorphism CTSB rs12898 is associated with primary hepatic cancer in a Chinese population.

Authors:  Minghua Cui; Quanzhu Chen; Chaojun He; Nan Wang; Yong Yu; Ziyang Sun; Zhenhua Lin; Hesong Cui; Shengyu Jin; Jae Yong Park; Guang Jin; Shin Yup Lee; Qingsong Cui
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

3.  Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single, small hepatocellular carcinomas.

Authors:  Juxian Song; Yu Wang; Kuansheng Ma; Shuguo Zheng; Ping Bie; Feng Xia; Xiaowu Li; Jianwei Li; Xiaojun Wang; Jian Chen
Journal:  Surg Endosc       Date:  2015-12-29       Impact factor: 4.584

Review 4.  Associated liver partition and portal vein ligation for staged hepatectomy: a review.

Authors:  Kai Siang Chan; Jee Keem Low; Vishal G Shelat
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

5.  Association of p53 codon 72 polymorphism with susceptibility to hepatocellular carcinoma in a Chinese population from northeast Sichuan.

Authors:  Jiajing Cai; Yan Cai; Qiang Ma; Fan Chang; Lei Xu; Guoyuan Zhang; Xiaolan Guo
Journal:  Biomed Rep       Date:  2017-01-11

Review 6.  Association between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysis.

Authors:  Shijie Zhang; Hexing Wu; Xiangwei Wu; Webo Lian; Yanchao Wang; Xiaozhao Zhang; Xinyu Peng
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 7.  Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients.

Authors:  Gul M Mustafa; Denner Larry; John R Petersen; Cornelis J Elferink
Journal:  World J Hepatol       Date:  2015-06-08

8.  Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.

Authors:  Duo Zuo; Liwei Chen; Xiaoqian Liu; Xia Wang; Qing Xi; Yi Luo; Ning Zhang; Hua Guo
Journal:  Tumour Biol       Date:  2015-12-04

9.  Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.

Authors:  Diren Beyoğlu; Sandrine Imbeaud; Olivier Maurhofer; Paulette Bioulac-Sage; Jessica Zucman-Rossi; Jean-François Dufour; Jeffrey R Idle
Journal:  Hepatology       Date:  2013-05-08       Impact factor: 17.425

Review 10.  Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.

Authors:  Weihong Hou; Herbert L Bonkovsky
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.